Georgia's Online Cancer Information Center

Find A Clinical Trial

A Phase 2, Open-Label, Monotherapy, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement

Status
Active
Cancer Type
Eye Cancer
Leukemia
Trial Phase
Phase II
Eligibility
18 and over, Male and Female
Study Type
Treatment
NCD ID
NCT03011372
Protocol IDs
INCB 54828-203 (primary)
NCI-2017-00141
Study Sponsor
Incyte Corporation

Summary

The purpose of this study is to evaluate the efficacy and safety of INCB054828 in subjects

with myeloid/lymphoid neoplasms with fibroblast growth factor receptor (FGFR) 1

rearrangement.

Treatment Sites in Georgia

Winship Cancer Institute of Emory University


1365 Clifton Road NE
Building C
Atlanta, GA 30322
404-778-5180
winshipcancer.emory.edu

Georgia CORE

 

Hearts and Minds Dedicated to Improving Cancer Care

Georgia CORE is a public-private partnership that creates collaboration among the state’s cancer organizations and institutions to connect more Georgians to quality, personalized cancer care. We welcome you to this one-of-a-kind online information center for all things related to cancer and survivorship care in Georgia.